RADIOTHERAPY

This study is testing a treatment approach for muscle-invasive bladder cancer that aims to avoid removing the bladder through major surgery. Participants receive a combination of chemotherapy, immunotherapy (toripalimab), and radiation therapy. The goal is to see if this non-surg…

This large Phase 3 trial is testing whether doctors can safely reduce the size of the radiation treatment area for patients with advanced nasopharyngeal (upper throat) cancer. The study compares targeting the original tumor size versus the smaller size after initial chemotherapy,…

This study is testing if adding an immunotherapy drug (camrelizumab) to standard radiation helps shrink tumors before surgery for esophageal cancer. It involves 25 adults with a specific type of operable esophageal cancer who have not had prior treatment. The main goals are to se…

This study is testing whether adding a drug called olaparib to the standard radiation and chemotherapy treatment can help patients with aggressive, inoperable brain tumors live longer. The goal is to see if olaparib makes the cancer cells more sensitive to the damaging effects of…

This study is testing a new combination treatment for people with esophageal cancer that is difficult or impossible to remove with surgery right away. The goal is to see if adding a very low dose of radiation to the intestines to an immunotherapy and chemotherapy regimen can shri…

This study aims to find better ways to monitor and treat a specific type of cervical cancer (adenocarcinoma) after patients complete initial radiation and chemotherapy. It will follow 60 patients to see if detailed imaging and tissue analysis can help doctors decide the best next…

This early-stage trial is testing whether injecting a nanoparticle called NBTXR3 directly into a tumor, then activating it with radiation, can make immunotherapy work better for people with advanced cancers. The study will enroll about 145 patients with various cancers that have …

This study is testing whether a shorter, 1-week radiation treatment is as effective as the standard 3-week treatment for breast cancer patients who need radiation after surgery. The main goal is to see if the shorter treatment causes less arm swelling (lymphedema) while still con…

This study aims to develop better methods for monitoring how rectal cancer responds to chemotherapy and radiation treatment. Researchers will track 40 patients using repeated MRI scans and blood tests to detect cancer cells during their treatment. The goal is to create a model th…

This study tests whether adding weekly check-ins with specially trained medical technicians helps doctors better identify and track treatment side effects in patients receiving proton therapy for brain tumors. The trial involves 92 adult patients and randomly assigns them to rece…